Veronica Mollica
Via Albertoni-15
Bologna, 40138, Italy
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 240 publications
YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025.
Journal: Minerva urology and nephrology
Published: July 13, 2026
YAU-RCC Insights from ASCO GU 2026: emerging advances in renal cell carcinoma management.
Journal: Minerva urology and nephrology
Published: July 07, 2026
KIM-1 and beyond: emerging biomarkers for adjuvant immunotherapy in clear cell renal cell carcinoma.
KIM-1 and beyond: emerging biomarkers for adjuvant immunotherapy in clear cell renal cell carcinoma.
Journal: Expert review of molecular diagnostics
Published: June 09, 2026
Pattern-based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements.
Journal: Histopathology
Published: May 06, 2026
What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.
Journal: World journal of urology
Published: April 24, 2026
Immunohistochemical characterization of somatically derived "yolk sac tumors": analysis of a multi-institutional case series.
Journal: Virchows Archiv : an international journal of pathology
Published: April 23, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 14, 2026
Oncofertility in Women with Renal Cell Carcinoma in the Immune Checkpoint Inhibitors Era: A Multidisciplinary Perspective.
Journal: Journal of clinical medicine
Published: February 26, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.
Journal: Diagnostics (Basel, Switzerland)
Published: February 22, 2026
The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study.
Journal: The oncologist
Published: February 08, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.
Journal: Expert opinion on pharmacotherapy
Published: February 04, 2026
Last Updated: 09/26/2026